Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The ABCG transporter OsPDR17 mediates transport of 5,10-diketo-casbene and enhances disease resistance in rice.

Created on 03 Oct 2026

Authors

Ruyuan Wang, Xuesong Bie, Shu Xu, Linwei Li, Pirui Li, Hui Lyu, Lukas Ernst, Xu Feng, Yelong Sheng, Yu Chen

Published in

The New phytologist. Oct 03, 2026. Epub Oct 03, 2026.

Abstract

Compound 5,10-diketo-casbene (DKC) is a key macrocyclic diterpenoid phytoalexin contributing to rice resistance against bacterial blight. Although its activity depends on transmembrane transport, the transporter of DKC remains unknown. Using transcriptome profiling and a yeast expression system, OsPDR17, an ABCG transporter, was identified and functionally characterized as the major DKC transporter. Its role during Xanthomonas oryzae pv oryzae infection was examined via CRISPR/Cas9 and overexpression, and a transcription factor regulating OsPDR17 was identified. OsPDR17 was localized to the chloroplast membrane, and key enzymes for DKC biosynthesis were chloroplast-localized proteins. OsPDR17 knockout significantly suppressed the expression of DKC biosynthetic genes, reduced DKC accumulation, and weakened resistance to bacterial blight, whereas overexpression of OsPDR17 showed opposite effects. Notably, we revealed that residue D1149 was essential for OsPDR17-DKC the interaction using molecular docking and site-directed mutagenesis analysis. In addition, WRKY10, a known transcription factor of DKC biosynthetic genes, was found to be potentially involved in regulating OsPDR17 expression. Taken together, this work uncovered the pivotal function of OsPDR17 in rice resistance to bacterial blight, mediating the transport of phytoalexin DKC and orchestrating feedback regulation of DKC biosynthesis. These results offered a theoretical insight and an important genetic resource for rice disease resistance research.

PMID:
42827415
Bibliographic data and abstract were imported from PubMed on 03 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 19
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement